Longeveron Inc. (NASDAQ:LGVN) Q4 2023 Earnings Conference Call February 27, 2024 5:00 PM ET
Company Participants
Mike Moyer – Managing Director
Wa'el Hashad – Chie Executive Officer
Nataliya Agafonova – Chief Medical Officer
Lisa Locklear – Chief Financial Officer
Conference Call Participants
Dipesh Patel – H.C. Wainwright
Michael Okunewitch – Maxim Group
Brad Sorensen – Zacks Research
Operator
Ladies and gentlemen, good afternoon, and welcome to the Longeveron Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mike Moyer, Managing Director of LifeSci Advisors. Please go ahead.
Mike Moyer
Thank you, operator. Good afternoon, everyone, and welcome to Longeveron's 2023 year-end results conference call. Today, we will discuss financial results from the year ended December 31, 2023, and provide a business update. After the market closed today, we issued a press release with these results, which can be found under the Investors section of the Longeveron website.
I'm joined on the call today by the following members of Longeveron's management team. Mr. Wa'el Hashad, Chief Executive Officer; Dr. Nataliya Agafonova, Chief Medical Officer; and Lisa Locklear, Chief Financial Officer. Mr. Hashad will begin with a brief corporate update, then Dr. Agafonova will review Longeveron's progress in its clinical programs and Ms. Locklear will review financial results for 2023.
Following the company's prepared remarks, we will open the call to questions from covering analysts. As a reminder, during this call, we will make forward-looking statements, which are subject to various risks and uncertainties that could cause our actual results to differ materially from these statements. Any such statements should be considered in conjunction with cautionary statements in our press releases and risk factors discussed in our filings with the SEC, including our quarterly reports on Form 10-Q and annual report on Form 10-K and cautionary statements made during this call. We assume no obligation to update any of these forward-looking statements or information.
Now I'd like to turn the call over to Mr. Wa'el Hashad, Chief Executive Officer of Longeveron. Wa'el?
Wa'el Hashad
Thank you, Mike. Good afternoon, everyone. We are pleased speaking with you today. On this call, we briefly recap of the major highlight of our year 2023 and outline strategic priorities for 2024. Then we will be happy to answer any questions you have.